Parametric Portfolio Associates’s Theravance Biopharma TBPH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$707K Sell
73,983
-623
-0.8% -$5.95K ﹤0.01% 2939
2021
Q4
$824K Buy
74,606
+29,278
+65% +$323K ﹤0.01% 2863
2021
Q3
$335K Buy
45,328
+24,028
+113% +$178K ﹤0.01% 3257
2021
Q2
$309K Buy
21,300
+1,097
+5% +$15.9K ﹤0.01% 3260
2021
Q1
$412K Sell
20,203
-1,554
-7% -$31.7K ﹤0.01% 3584
2020
Q4
$387K Sell
21,757
-2,664
-11% -$47.4K ﹤0.01% 3492
2020
Q3
$361K Sell
24,421
-60,855
-71% -$900K ﹤0.01% 3410
2020
Q2
$1.79M Buy
85,276
+28,108
+49% +$590K ﹤0.01% 2565
2020
Q1
$1.32M Buy
57,168
+25,692
+82% +$594K ﹤0.01% 2625
2019
Q4
$815K Sell
31,476
-24,097
-43% -$624K ﹤0.01% 3160
2019
Q3
$1.08M Buy
55,573
+37,022
+200% +$721K ﹤0.01% 2977
2019
Q2
$303K Sell
18,551
-2,570
-12% -$42K ﹤0.01% 3578
2019
Q1
$479K Buy
21,121
+1,139
+6% +$25.8K ﹤0.01% 3360
2018
Q4
$511K Buy
19,982
+4,659
+30% +$119K ﹤0.01% 3300
2018
Q3
$501K Buy
15,323
+2,184
+17% +$71.4K ﹤0.01% 3416
2018
Q2
$298K Sell
13,139
-15,543
-54% -$353K ﹤0.01% 3557
2018
Q1
$696K Buy
28,682
+9,248
+48% +$224K ﹤0.01% 3190
2017
Q4
$542K Buy
19,434
+4,642
+31% +$129K ﹤0.01% 3285
2017
Q3
$506K Buy
14,792
+549
+4% +$18.8K ﹤0.01% 3416
2017
Q2
$567K Buy
14,243
+153
+1% +$6.09K ﹤0.01% 3290
2017
Q1
$519K Buy
14,090
+456
+3% +$16.8K ﹤0.01% 3187
2016
Q4
$435K Buy
13,634
+1,063
+8% +$33.9K ﹤0.01% 3262
2016
Q3
$456K Sell
12,571
-1,531
-11% -$55.5K ﹤0.01% 3216
2016
Q2
$320K Buy
14,102
+3,314
+31% +$75.2K ﹤0.01% 3424
2016
Q1
$203K Sell
10,788
-524
-5% -$9.86K ﹤0.01% 3735
2015
Q4
$185K Buy
+11,312
New +$185K ﹤0.01% 3749